News

Filter

Current filters:

LyxumiaVictoza

Highlights of American Diabetes Association meeting

11-06-2012

The weekend saw a flood of new data on diabetes drug candidates and currently approved treatments presented…

Boehringer IngelheimDegludecDiabetesEli LillyempagliflozinLyxumiaNovo NordiskPharmaceuticalResearchSanofiTradjentaVictoza

Most surveyed physicians in Europe expect to increase Rxing of GLP-1 analogues and DPP-IV inhibitors

18-08-2011

Almost all surveyed physicians in each of the top European Union countries (France, Germany, Italy, Spain…

BydureonDiabetesEuropeGalvusJanuviaLyxumiaMarkets & MarketingNesinaOnglyzaPharmaceuticalTradjentaVictoza

Highlights from American Diabetes Association meeting

27-06-2011

There was a batch of good news coming out of the American Diabetes Association (ADA) 71st annual scientific…

ApidraAstraZenecaBristol-Myers SquibbdapagliflozinDiabetesLantusLyxumiaNovo NordiskOnglyzaPharmaceuticalResearchSanofiVictoza

COMPANY SPOTLIGHT

Menarini

Back to top